Atrion Reports First Quarter Results

Atrion Reports First Quarter Results

ID: 144157

(firmenpresse) - ALLEN, TX -- (Marketwire) -- 05/08/12 -- Atrion Corporation (NASDAQ: ATRI) today announced that for the first quarter of 2012 diluted earnings per share were 22% lower than in the first quarter of 2011, and revenues for the quarter were down 4% compared to the first quarter of 2011.

Commenting on the Company's performance, David A. Battat, President & CEO, said, "The inventory adjustment by a long-term ophthalmic customer that was fully detailed in our February 21, 2012 press release announcing results for 2011 led to the predicted decline in operating income of 21% compared to the comparable quarter last year. While overall sales were down by $1.4 million, ophthalmic products showed a decline of $1.9 million. Although we are disappointed with the results for the first quarter of 2012, it is worth noting that we are comparing our 2012 results to a period of exceptionally strong performance last year when first quarter operating income was up 43% over the same quarter of 2010. Additionally, even with the burden of the customer inventory adjustment, our first quarter results showed a gross profit margin of 47% and an annualized return on equity of 15% even though cash and short and long term investments, which were equal to 40% of stockholder's equity, generated low returns from earned interest." Mr. Battat added, "We continue to expect that our customer's inventory correction will taper off as the year progresses, with full year 2012 showing an overall decline in our operating income of about 10%. Moreover, we expect to continue to exhibit high returns on equity even as we make major additions to tooling and automation and selectively add exceptional talents in engineering, R&D, and corporate development. Recognizing our growth potential, we purchased during the first quarter 10,000 shares of our stock in open market transactions at an average price of $202 per share."

Atrion's revenues for the quarter ended March 31, 2012 were $29,239,000 compared with $30,589,000 in the same period in 2011. Net income in the current year quarter totaled $5,377,000 compared to $6,858,000 in last year's first quarter. On a diluted per share basis, earnings for the period decreased to $2.65 as compared to $3.38 in the first quarter of last year.





Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is .

Statements in this press release that are forward looking are based upon current expectations and actual results or future events may differ materially. Such statements include, but are not limited to, Atrion's expectations regarding the inventory correction by a Company customer, full year 2012 operating income, returns on equity and additions to tooling, automation and personnel. Words such as "expects," "believes," "anticipates," "intends," "should", "plans," "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve risks and uncertainties. The following are some of the factors that could cause actual results or future events to differ materially from those expressed in or underlying our forward-looking statements: changing economic, market and business conditions; acts of war or terrorism; the effects of governmental regulation; competition and new technologies; slower-than-anticipated introduction of new products or implementation of marketing strategies; the Company's ability to protect its intellectual property; changes in the prices of raw materials; changes in product mix; and intellectual property and product liability claims and product recalls. The foregoing list of factors is not exclusive, and other factors are set forth in the Company's filings with the Securities and Exchange Commission.









Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Study Reveals Many Canadians Unnecessarily Living With Vision Loss Trimel Pharmaceuticals Corporation Announces First Quarter 2012 Financial Results and Provides Product Development Update
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 08.05.2012 - 20:30 Uhr
Sprache: Deutsch
News-ID 144157
Anzahl Zeichen: 0

contact information:
Town:

ALLEN, TX



Kategorie:

Healthcare



Diese Pressemitteilung wurde bisher 159 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Atrion Reports First Quarter Results"
steht unter der journalistisch-redaktionellen Verantwortung von

Atrion Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Atrion Reports Second Quarter Results ...

ALLEN, TX -- (Marketwired) -- 08/04/15 -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2015 revenues totaled $37.7 million compared with $35.0 million in the same period in 2014. On a diluted per share ...

Atrion Corporation Increases Quarterly Cash Dividend by 20% ...

ALLEN, TX -- (Marketwired) -- 08/04/15 -- Atrion Corporation (NASDAQ: ATRI) today announced an increase in its quarterly cash dividend from 75 cents per share to 90 cents per share. Specifically, the Board of Directors declared a quarterly dividend ...

Atrion Corporation Declares Quarterly Cash Dividend ...

ALLEN, TX -- (Marketwired) -- 05/21/15 -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share on the Company's outstanding Common Stock. This dividend will be payab ...

Alle Meldungen von Atrion Corporation



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z